MiMedx says US FDA's warning letter for Axiofill not related to safety

MiMedx

29/12/2023 22:12

Dec 29 (Reuters) - MiMedx Group  MDXG.O  said on Friday
the U.S. Food and Drug Administration's warning letter for its
recently launched placental-derived tissue product Axiofill was
not related to safety.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shounak
Dasgupta)
 ((Sriparna.Roy@thomsonreuters.com))